The Global PuraStat Dinner Grandior Hotel Prague on Thursday 28th April 2022

On Thursday 28th April 2022, 3-D Matrix, in collaboration with FUJIFILM, hosted their first global ...

3-D Matrix ranked in the Top 500 Fastest Growing Companies in Asia-Pacific region published by Financial Times

We are pleased to share that 3-D Matrix has been ranked 179th on the list of the 500...

Meet the Expert in Germany -  PuraStat: Looking Beyond Haemostasis

On the 23rd of February, 3-D Matrix continued its Meet the Expert series with "PuraStat: Looking...

Controlled Trial to Evaluate the Efficacy of PuraStat in Reducing  Delayed Bleeding (in high-risk patients) After Colonic Endoscopic Submucosal Dissection Has Started in France.

The new clinical trial “Multicentre Randomised Controlled Trial (RCT) to assess the efficacy of a...

First Human Clinical Investigation of the Next Generation Self-Assembling Haemostat [in progress]

The clinical investigation ‘First-in-Human Trial of the Safety and Performance of NU-MAX® as a...

Global news: Japan Published Their First PuraStat Case Report

Last month, the first PuraStat case report in Japan was published. Written by Dr Takuto Hikichi (...

Prof Di Bartolomeo Chairs 3-D Matrix Cardiac Symposium

On Thursday 14th October 2021, 3-D Matrix hosted a hybrid symposium, ‘Haemostasis in Cardiac Surgery

Study on PuraStat's Efficacy in Liver Resection Bleeding Now Published

New clinical trial data with PuraStat is now available in the publication “A multi-centre...

RCT Study: Exploring Efficacy of PuraStat in EMR Surgeries Goes Live

The clinical trial ‘Colorectal EMR & Delayed Bleeding: Prospective multicentre randomised...

PuraStat: The Impact on Patient Care Now and the Future

On Wednesday 20th October 2021, 3-D Matrix (in partnership with FUJIFILM) hosted its biannual...